And here’s the Lancet study from China showing no mortality benefit from remdesivir:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext?utm_campaign=tlcoronavirus20&utm_source=twitter&utm_medium=social …
-
-
This is
#regulatorycapture in action. Remdesivir, from all I can see, was a reasonable drug to try against#COVID19. There are lots of other reasonable drugs to try. Only the ones with deep pockets and good political relationships will get approved.Show this thread -
And then people will say “Science Says these are the good drugs and the others are bad” but never ask who determines *which* science gets done
Show this thread -
What ordinary lay humans care about — can this drug save lives? can it make
#COVID19 close to harmless? — is not even being tested!!!Show this thread -
“Hydroxychloroquine doesn’t have an RCT and remdesivir does!” Yes, true, and ALSO notice that hydroxychloroquine is a cheap generic so there’s nobody to *pay* for a big RCT.
Show this thread -
And the public only knows about hydroxychloroquine because there’s this one doc with a bee in his bonnet about it (and he’s probably biased and sloppy and goes to the media too early and exaggerates.)
Show this thread -
If it’s a cheap generic that *doesn’t* have a crazed fanboy, it’ll have even less apparent “success.” When was the last time you heard Discourse about indomethacin or niclosamide?
Show this thread -
If you don’t like that the “standard of care” is biased towards the interests of a handful of pharma companies...maybe the problem is that you need to be a hundred-billion-dollar company to run a clinical trial that satisfies today’s FDA?
Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.